Year: 2019

TORONTO, Nov. 27, 2019 (GLOBE NEWSWIRE) — Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce its interim financial results for the three and nine months ended September 30, 2019. The financial statements and management discussion and analysis for such interim periods are available on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com and on Eve & Co’s website at www.evecannabis.ca.HIGHLIGHTSThe Company is pleased to provide the following highlights of its progress over the three and nine months ended September 30, 2019 and subsequent events:For the three months ended September 30, 2019, the Company reported revenue of $0.9 million, a 45% increase over the three months ended June 30, 2019, as the Company continued...

Savosolar PlcCompany Announcement            27 November 2019 at 1.45 p.m. (CET)SAVOSOLAR PLCFor more information:Savosolar PlcManaging Director Jari VarjotiePhone: +358 400 419 734E-mail: jari.varjotie@savosolar.comThe company’s Certified Adviser is Augment Partners AB, info@augment.se, phone: +46 8-505 65 172.

Savosolar OyjYhtiötiedote                                       27.11.2019 klo 13.45 (CET)SAVOSOLAR OYJLisätietoja: Toimitusjohtaja Jari VarjotiePuh: +358 400 419 734Sähköposti: jari.varjotie@savosolar.comYhtiön Hyväksytty Neuvonantaja on Augment Partners AB, info@augment.se, puh. +46 8 505 65 172.

ROCHESTER, N.Y., Nov. 27, 2019 (GLOBE NEWSWIRE) — Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced that its Board of Directors has declared a quarterly cash dividend of $.22 per share on the Company’s outstanding shares of common stock, including the shares of common stock to which the holders of the Company’s Class C Convertible Preferred Stock are entitled. The dividend is payable on December 24, 2019 to shareholders of record at the close of business on December 10, 2019. About Monro, Inc.Headquartered in Rochester, New York, Monro is a chain of 1,271 Company-operated stores, 98 franchised locations, eight wholesale locations and three retread facilities providing automotive undercar repair and tire sales and services. The Company operates in 32 states, serving the...

RADNOR, Pa., Nov. 27, 2019 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that two abstracts highlighting ganaxolone data have been selected for poster presentation at the American Epilepsy Society (AES) Annual Meeting in Baltimore, Maryland on December 7 and 8, 2019. Details for the poster presentations at the AES Annual Meeting:“Pharmacokinetic and Pharmacodynamic (PK/PD) Relationship of Intravenous Ganaxolone in Refractory Status Epilepticus” R.E. Ramsay, et al.Abstract # 1.136 Saturday, December 712:00 pm to 6:00 pm“Population Pharmacokinetic/Pharmacodynamic Modeling of the Electroencephalographic Effects of Ganaxolone in Healthy Subjects” A.M. Hussain, et al.Abstract...

BROOKINGS, S.D., Nov. 27, 2019 (GLOBE NEWSWIRE) — Daktronics, Inc. (NASDAQ – DAKT) today reported fiscal 2020 second quarter net sales of $174.9 million, operating income of $4.8 million, and net income of $7.3 million, or $0.16 per diluted share, compared to net sales of $172.7 million, operating income of $9.0 million, and net income of $8.6 million, or $0.19 per diluted share, for the second quarter of fiscal 2019.  Fiscal 2020 second quarter orders were $151.1 million, compared to $151.4 million for the second quarter of fiscal 2019.  Product order backlog at the end of the fiscal 2020 second quarter was $182 million, compared to $150 million a year earlier and $207 million at the end of the first quarter of fiscal 2020.(1)For the six months ended November 2, 2019, net sales were $355.2 million, operating income was $12.4...

NEW HAVEN, Conn., Nov. 27, 2019 (GLOBE NEWSWIRE) — Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Ian Taylor, Ph.D., Chief Scientific Officer, will participate in a fireside chat at the 31st Annual Piper Jaffray Healthcare Conference on Thursday, December 5 at 12:00 p.m. ET in New York, NY.A live audio webcast of the presentation will be available on the Company’s website at www.arvinas.com. A replay of the webcast will be archived on the Arvinas website for 30 days following the presentation.About ArvinasArvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that...

HARRISBURG, Pa., Nov. 27, 2019 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (Nasdaq: OLLI) announced today that it will release its financial results for the third quarter of fiscal 2019 on Tuesday, December 10, 2019 after the market closes.  Following the release, at 4:30 p.m. Eastern Time the Company’s management will host a conference call to discuss the results. Investors and analysts can participate on the conference call by dialing (800) 219-7052 or (574) 990-1029 and using conference ID #9986568. Interested parties can also listen to a live webcast or replay of the conference call by logging on to the Investor Relations section on the Company’s website at http://investors.ollies.us/.About Ollie’sWe are a highly differentiated and fast growing, extreme value retailer of brand name merchandise at drastically reduced...

TORONTO, Nov. 27, 2019 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX/TSX: CDV) (“Cardinal” or the “Company”) is pleased to announce that it has filed a National Instrument 43-101 (“NI 43-101”) Technical Report in respect of the Feasibility Study for the Namdini Gold Project (“Namdini”) in Ghana, West Africa, announced on 28 October 2019.The NI 43-101 Technical Report can be viewed under the Company’s issuer profile on SEDAR at www.sedar.com and on the Company’s website at www.cardinalresources.com.au.ABOUT CARDINALCardinal Resources Limited (ASX/TSX: CDV) is a West African gold‐focused exploration and development Company which holds interests in tenements within Ghana, West Africa.The Company is focused on the development of the flagship Namdini Gold Project.Exploration programmes are...

VANCOUVER, British Columbia, Nov. 27, 2019 (GLOBE NEWSWIRE) — Balmoral Resources Ltd. (“Balmoral” or the “Company”) (TSX: BAR; OTCQX: BALMF) announced today that is has acquired by staking 62 mineral claims located adjacent to its existing Detour East property in Quebec. The Detour East property, and the claims staked, form part of the Company’s Detour Gold Trend Project and are located along and proximal to the Ontario-Quebec border where they adjoin the holdings of Detour Gold Corporation (“Detour Gold” or the “Corporation”). On November 25, 2019 Detour Gold announced that they had entered into a definitive agreement to sell the Corporation, subject to shareholder approval, in a deal with a pre-announcement implied equity valuation of approximately CDN$4.9 billion*.The potential acquisition of Detour Gold, combined with recent...